Updates in Treatment of Adult Spinal Muscular Atrophy

James Wymer, MD, FAAN, explains what spinal muscular atrophy is and discusses how the disease typically presents in newly diagnosed patients.

Tim Hagenacker, MD, describes spinal muscular atrophy as a very broad clinical spectrum disease, highlighting the various ways it can present in patients.

The rationale behind genetic testing in spinal muscular atrophy and the importance of detecting the SMN1 and SMN2 genes when diagnosing the condition.

Drs Tim Hagenacker and James Wymer discuss how the age at which spinal muscular atrophy is diagnosed in patients correlates with disease severity and highlight conditions that are included in the differential diagnosis of the condition.

James Wymer, MD, FAAN, discusses the use of motor testing to assess patients with later-onset spinal muscular atrophy and scales for assessing patients’ developmental milestones, as well as remarks on what is currently understood regarding decline in motor function.
SAP Partner Banner